Skip to main content
Top
Published in: Clinical & Experimental Metastasis 3/2008

01-05-2008 | Research Paper

Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential

Authors: Zhongyong Li, Zhiyi Zhou, Henry J. Donahue

Published in: Clinical & Experimental Metastasis | Issue 3/2008

Login to get access

Abstract

Emerging evidence suggests that gap junctional intercellular communication (GJIC) and expression of connexins (Cx) contribute to the metastatic potential of breast cancer cells. To more directly address this, an aggressive bone metastasis breast cancer cell line, MDA-MET (MET), was stably transfected with human Cx43 cDNA (MET/Cx43+). Focusing on clone 28 of MET/Cx43+, we demonstrated that GJIC, Cx43 protein and Cx43 mRNA were significantly increased in MET/Cx43+ cells relative to MET, the plasmid control for the Cx43 transfectants (MET/HY) and a metastatic breast cancer cell that is less metastatic to bone than MET, MDA-MB-231. Cx26 mRNA was also increased in MET/Cx43+ clone 28 cells while mRNA for Cx32, Cx37, Cx40 and Cx45 were not detected in any of the breast cancer cell lines examined. MET/Cx43+ clone 28 invasiveness was decreased by 33% relative to MET/HY, while their ability to migrate was unchanged. The ability of MET/Cx43+ clone 28 cells to adhere to hFOB and HUV-EC-C cells was decreased approximately 30% and 70%, respectively, relative to MET and MET/HY. E-cadherin and N-cadherin proteins were not detected in MET, MDA-MB-231, MET/Cx43+ clone 28 and MET/HY cells. However, OB-cadherin protein levels were decreased approximately 43% in MET/Cx43+ clone 28 relative to MET/HY cells. These findings suggest that GJIC and Cx43 expression contribute to breast cancer cell adhesion and migration, possibly through a mechanism involving OB-cadherin, and these changes in turn regulate the metastatic potential of breast cancer cells, especially to bone.
Literature
1.
go back to reference Pozzi A, Risek B, Kiang DT et al (1995) Analysis of multiple gap junction gene products in the rodent and human mammary gland. Exp Cell Res 220(1):212–219PubMedCrossRef Pozzi A, Risek B, Kiang DT et al (1995) Analysis of multiple gap junction gene products in the rodent and human mammary gland. Exp Cell Res 220(1):212–219PubMedCrossRef
2.
go back to reference Loewenstein WR, Kanno Y (1966) Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature 209(29):1248–1249PubMedCrossRef Loewenstein WR, Kanno Y (1966) Intercellular communication and the control of tissue growth: lack of communication between cancer cells. Nature 209(29):1248–1249PubMedCrossRef
3.
go back to reference Saunders MM, Seraj MJ, Li Z et al (2001) Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Research 61(5):1765–1767PubMed Saunders MM, Seraj MJ, Li Z et al (2001) Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Research 61(5):1765–1767PubMed
4.
go back to reference Kapoor P, Saunders MM, Li Z et al (2004) Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer 111(5):693–697PubMedCrossRef Kapoor P, Saunders MM, Li Z et al (2004) Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer 111(5):693–697PubMedCrossRef
5.
go back to reference Ito A, Katoh F, Kataoka TR et al (2000) A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest 105(9):1189–1197PubMedCrossRef Ito A, Katoh F, Kataoka TR et al (2000) A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest 105(9):1189–1197PubMedCrossRef
6.
go back to reference Pollmann MA, Shao Q, Laird DW et al (2005) Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res 7(4):R522–R534PubMedCrossRef Pollmann MA, Shao Q, Laird DW et al (2005) Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res 7(4):R522–R534PubMedCrossRef
7.
go back to reference Bendre MS, Gaddy-Kurten D, Mon-Foote T et al (2002) Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res 62(19):5571–5579PubMed Bendre MS, Gaddy-Kurten D, Mon-Foote T et al (2002) Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res 62(19):5571–5579PubMed
8.
go back to reference Harris SA, Enger RJ, Riggs BL et al (1995) Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10(2):178–186PubMedCrossRef Harris SA, Enger RJ, Riggs BL et al (1995) Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10(2):178–186PubMedCrossRef
9.
go back to reference Li Z, Zhou Z, Saunders MM et al (2006) Modulation of connexin43 alters expression of osteoblastic differentiation markers. Am J Physiol Cell Physiol 290(4):C1248–C1255PubMedCrossRef Li Z, Zhou Z, Saunders MM et al (2006) Modulation of connexin43 alters expression of osteoblastic differentiation markers. Am J Physiol Cell Physiol 290(4):C1248–C1255PubMedCrossRef
10.
go back to reference De Bruyn PP (1981) Structural substrates of bone marrow function. Semin Hematol 18(3):179–193PubMed De Bruyn PP (1981) Structural substrates of bone marrow function. Semin Hematol 18(3):179–193PubMed
11.
go back to reference Chole RA, Tinling SP (1994) Bone lining cells of the mammalian cochlea. Hear Res 75(1–2):233–243PubMedCrossRef Chole RA, Tinling SP (1994) Bone lining cells of the mammalian cochlea. Hear Res 75(1–2):233–243PubMedCrossRef
12.
go back to reference Schweitzer KM, Vicart P, Delouis C et al (1997) Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest 76(1):25–36PubMed Schweitzer KM, Vicart P, Delouis C et al (1997) Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. Lab Invest 76(1):25–36PubMed
13.
go back to reference Hillyer P, Mordelet E, Flynn G et al (2003) Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin Exp Immunol 134(3):431–441PubMedCrossRef Hillyer P, Mordelet E, Flynn G et al (2003) Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin Exp Immunol 134(3):431–441PubMedCrossRef
14.
go back to reference Trosko J, Ruch R (1998) Cell–cell communication in carcinogenesis. Front Biosci 3:d208–d236PubMed Trosko J, Ruch R (1998) Cell–cell communication in carcinogenesis. Front Biosci 3:d208–d236PubMed
15.
go back to reference Perl AK, Wilgenbus P, Dahl U et al (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392(6672):190–193PubMedCrossRef Perl AK, Wilgenbus P, Dahl U et al (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392(6672):190–193PubMedCrossRef
16.
go back to reference Moll R, Mitze M, Frixen UH et al (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143(6):1731–1742PubMed Moll R, Mitze M, Frixen UH et al (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143(6):1731–1742PubMed
17.
go back to reference Nieman MT, Prudoff RS, Johnson KR et al (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147(3):631–644PubMedCrossRef Nieman MT, Prudoff RS, Johnson KR et al (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147(3):631–644PubMedCrossRef
18.
go back to reference Hazan RB, Phillips GR, Qiao RF et al (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148(4):779–790PubMedCrossRef Hazan RB, Phillips GR, Qiao RF et al (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148(4):779–790PubMedCrossRef
19.
go back to reference Kawaguchi J, Kii I, Sugiyama Y et al (2001) The transition of cadherin expression in osteoblast differentiation from mesenchymal cells: consistent expression of cadherin-11 in osteoblast lineage. J Bone Miner Res 16(2):260–269PubMedCrossRef Kawaguchi J, Kii I, Sugiyama Y et al (2001) The transition of cadherin expression in osteoblast differentiation from mesenchymal cells: consistent expression of cadherin-11 in osteoblast lineage. J Bone Miner Res 16(2):260–269PubMedCrossRef
20.
go back to reference van Nimwegen MJ, van de Water B (2007) Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 73(5):597–609PubMedCrossRef van Nimwegen MJ, van de Water B (2007) Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 73(5):597–609PubMedCrossRef
21.
go back to reference Lark AL, Livasy CA, Dressler L et al (2005) High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod Pathol 18(10):1289–1294PubMedCrossRef Lark AL, Livasy CA, Dressler L et al (2005) High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype. Mod Pathol 18(10):1289–1294PubMedCrossRef
Metadata
Title
Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential
Authors
Zhongyong Li
Zhiyi Zhou
Henry J. Donahue
Publication date
01-05-2008
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 3/2008
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-007-9140-4

Other articles of this Issue 3/2008

Clinical & Experimental Metastasis 3/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine